Management of Lower Back Pain and Hip Stiffness in Patients with Type 2 Diabetes Mellitus and Hypertension

Introduction to Management

Regular moderate physical activity (at least 150 minutes per week) is recommended for patients with Type 2 diabetes mellitus and hypertension presenting with lower back pain and hip stiffness, as it helps with both pain management and improves glycemic and blood pressure control 1

The European Society of Cardiology recommends maintaining glycemic control with a target HbA1c <7.0% to reduce the risk of microvascular complications that could exacerbate musculoskeletal problems in patients with Type 2 diabetes mellitus 2
Metformin should be continued as first-line therapy if already prescribed and tolerated for patients with Type 2 diabetes mellitus and hypertension 3
For patients not at glycemic targets, SGLT2 inhibitors (such as empagliflozin, canagliflozin, or dapagliflozin) are recommended if the estimated glomerular filtration rate (eGFR) is 30 to <90 mL/min/1.73 m², according to the European Society of Cardiology 2
GLP-1 receptor agonists (such as liraglutide, semaglutide) should be considered if eGFR >30 mL/min/1.73m² for patients with Type 2 diabetes mellitus and hypertension 2

The European Society of Cardiology recommends a target blood pressure of <130/80 mmHg for most patients with diabetes and hypertension 4
For patients aged >65 years, a systolic BP target range of 130-140 mmHg is appropriate, as suggested by the European Society of Cardiology 4
An ACE inhibitor or ARB should be used as the cornerstone of pharmacological therapy for hypertension management in patients with Type 2 diabetes mellitus, according to the American Heart Association 5 and the European Society of Cardiology 4
If blood pressure remains uncontrolled, a calcium channel blocker or thiazide-like diuretic should be added, as recommended by the European Society of Cardiology 4
Multiple-drug therapy is often required to achieve blood pressure targets in patients with hypertension and Type 2 diabetes mellitus, as noted by the American Heart Association 6

Renal function and serum potassium should be monitored within 3 months of starting ACE inhibitors, ARBs, or diuretics in patients with Type 2 diabetes mellitus and hypertension, as advised by the American Heart Association 6
Home BP self-monitoring should be encouraged for patients with diabetes and hypertension, according to the European Society of Cardiology 4